Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Primary Care Companion to the Journal of Clinical Psychiatry
|
July 8, 2005
Atypical antipsychotics: sleep, sedation, and efficacy
Del D Miller
The American Journal of Psychiatry
|
March 4, 2003
Clozapine and tardive dyskinesia
Del D Miller
Journal of Child and Adolescent Psychopharmacology
|
April 14, 2011
Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents
Chadi Albert Calarge, Del D Miller
Clinics in Laboratory Medicine
|
September 14, 2010
Pharmacogenetics and schizophrenia
Adriana Foster, Del D Miller, Peter Buckley
The Psychiatric Clinics of North America
|
August 28, 2007
Pharmacogenetics and schizophrenia
Adriana Foster, Del D Miller, Peter F Buckley
The Journal of Clinical Psychiatry
|
December 29, 2007
Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis
Del D Miller, James M Eudicone, Andrei Pikalov, et al.
Human Psychopharmacology
|
February 24, 2011
Association between type-three metabotropic glutamate receptor gene (GRM3) variants and symptom presentation in treatment refractory schizophrenia
Jeffrey R Bishop, Del D Miller, Vicki L Ellingrod, et al.
Therapeutic Drug Monitoring
|
October 14, 2006
The relationship between P-glycoprotein (PGP) polymorphisms and response to olanzapine treatment in schizophrenia
Ying-Chi Lin, Vicki L Ellingrod, Jeffrey R Bishop, et al.
Biological Psychiatry
|
October 26, 2002
The effects of neuroleptic medications on basal ganglia blood flow in schizophreniform disorders: a comparison between the neuroleptic-naïve and medicated states
Patricia Westmoreland Corson, Daniel S O'Leary, Del D Miller, et al.
Schizophrenia Research
|
June 21, 2005
Clinicians' recognition of the metabolic adverse effects of antipsychotic medications
Peter F Buckley, Del D Miller, Beth Singer, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Primary Care Companion to the Journal of Clinical Psychiatry
|
July 8, 2005
Atypical antipsychotics: sleep, sedation, and efficacy
Del D Miller
The American Journal of Psychiatry
|
March 4, 2003
Clozapine and tardive dyskinesia
Del D Miller
Journal of Child and Adolescent Psychopharmacology
|
April 14, 2011
Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents
Chadi Albert Calarge, Del D Miller
Clinics in Laboratory Medicine
|
September 14, 2010
Pharmacogenetics and schizophrenia
Adriana Foster, Del D Miller, Peter Buckley
The Psychiatric Clinics of North America
|
August 28, 2007
Pharmacogenetics and schizophrenia
Adriana Foster, Del D Miller, Peter F Buckley
The Journal of Clinical Psychiatry
|
December 29, 2007
Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis
Del D Miller, James M Eudicone, Andrei Pikalov, et al.
Human Psychopharmacology
|
February 24, 2011
Association between type-three metabotropic glutamate receptor gene (GRM3) variants and symptom presentation in treatment refractory schizophrenia
Jeffrey R Bishop, Del D Miller, Vicki L Ellingrod, et al.
Therapeutic Drug Monitoring
|
October 14, 2006
The relationship between P-glycoprotein (PGP) polymorphisms and response to olanzapine treatment in schizophrenia
Ying-Chi Lin, Vicki L Ellingrod, Jeffrey R Bishop, et al.
Biological Psychiatry
|
October 26, 2002
The effects of neuroleptic medications on basal ganglia blood flow in schizophreniform disorders: a comparison between the neuroleptic-naïve and medicated states
Patricia Westmoreland Corson, Daniel S O'Leary, Del D Miller, et al.
Schizophrenia Research
|
June 21, 2005
Clinicians' recognition of the metabolic adverse effects of antipsychotic medications
Peter F Buckley, Del D Miller, Beth Singer, et al.
Page
of 4